WXXWY and 2269:HK Related Headlines

Go Back

Aug 28, 2026 09:18AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$60 at JPMorgan

Aug 28, 2026 03:01AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$62 at Citi

Aug 27, 2026 08:11AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$61 at Macquarie

Aug 26, 2026 06:50AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$60.22 at Nomura/Instinet

Aug 26, 2026 06:39AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$49 at Goldman Sachs

Aug 26, 2026 01:28AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$57 at Morgan Stanley

Jul 27, 2026 07:43AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51.38 at Nomura/Instinet

Jul 14, 2026 06:31AM Bernstein SocGen Group Starts Wuxi Biologics (2269:HK) (WXXWY) at Market Perform

Jul 13, 2026 07:58AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51.90 at CLSA

Apr 14, 2026 02:22AM Citi Resumes Wuxi Biologics (2269:HK) (WXXWY) at Buy

Mar 27, 2026 05:52AM Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$47 at JPMorgan

Mar 26, 2026 07:11AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$45 at Macquarie

Feb 27, 2026 08:44PM CLSA Reiterates Outperform (2) Rating on Wuxi Biologics (2269:HK) (WXXWY)

Feb 13, 2026 08:43AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51 at JPMorgan

Feb 12, 2026 06:51AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$50.54 at Nomura/Instinet

Jan 12, 2026 06:40AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$48.50 at CLSA

Dec 23, 2025 06:44AM HSBC Reiterates Buy Rating on Wuxi Biologics (2269:HK) (WXXWY)

Nov 28, 2025 08:22AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$37.36 at Nomura/Instinet

Oct 17, 2025 09:11AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$33.50 at Goldman Sachs

Sep 27, 2025 02:58AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$45 at HSBC

WXXWY and 2269:HK Related Press Releases

Go Back

WXXWY and 2269:HK Related SEC Filings

Go Back